WPA
RPRX icon

Wealth Preservation Advisors’s Royalty Pharma RPRX Stock Holding History

Wealth Preservation Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-237
Closed -$11.4K – 773
2026
Q1 		$11.4K Sell
237
-13
-5% -$569 0.01% 395
2025
Q4 		$9.66K Sell
250
-1
-0.4% -$38 ﹤0.01% 303
2025
Q3 		$8.86K Buy
251
+20
+9% +$724 0.01% 303
2025
Q2 		$8.32K Buy
231
+21
+10% +$696 0.01% 311
2025
Q1 		$6.54K Buy
+210
New +$6.66K ﹤0.01% 353

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Preservation Advisors's RPRX Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 237 shares — an estimated $11.4K sold.

Wealth Preservation Advisors first reported a position in RPRX in Q1 2025 and held it in 5 quarters. The position peaked at $11.4K in Q1 2026. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 237 Royalty Pharma shares in Q2 2026, an estimated $11.4K.
  • Wealth Preservation Advisors first reported a position in Royalty Pharma in Q1 2025 and held it in 5 quarters.
  • Wealth Preservation Advisors's Royalty Pharma position peaked at $11.4K in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.